| Title
| Author/Affiliation
| Source |
| 1. Enantioselective transformation of .alpha.,.beta.-unsaturated ketones using chiral organic catalysts [details]
| MacMillan, David W. C.; Northrup, Alan B.
California Institute of Technology, USA
| PCT Int. Appl.
WO2003047740 |
| 2. Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds by arylation and vinylation of amines, amides, hydrazides, heterocycles, alcohols, enolates, and malonates, using aryl, heteroaryl, and vinyl halides and analogs [details]
| Buchwald, Stephen L.; Klapars, Artis; et al.
Massachusetts Institute of Technology, USA
| PCT Int. Appl.
WO2002085838 |
| 3. Immobilization of oligonucleotides on nanoparticles and their use in nucleic acid hybridization [details]
| Mirkin, Chad A.; Letsinger, Robert L.; et al.
Nanosphere Inc., USA
| PCT Int. Appl.
WO2001051665 |
| 4. Preparation of benzimidazoles and analogs and their use as protein kinase inhibitors [details]
| Edwards, Michael Louis; Cox, Paul Joseph; et al.
Aventis Pharmaceuticals Inc., USA
| PCT Int. Appl.
WO2003035065 |
| 5. Atom or group transfer radical polymerization in the presence of transition metals [details]
| Matyjaszewski, Krzysztof; Gaynor, Scott G.; et al.
Carnegie Mellon University, USA
| U.S. Pat. Appl. Publ.
US6541580 |
| 6. High activity metal carbene metathesis catalysts generated using a thermally activated n-heterocyclic carbene precursor, preparation of heterocyclic carbene, and olefin reactions [details]
| Grubbs, Robert H.; Moore, Jason L.; et al.
USA
| U.S. Pat. Appl. Publ.
US2003083445 |
| 7. Preparation of pyridine derivatives as protein kinase inhibitors [details]
| Li, Qun; Woods, Keith W.; et al.
Abbott Laboratories, USA
| PCT Int. Appl.
WO2003051366 |
| 8. RNA interference mediated target discovery and target validation using short interfering nucleic acid (siNA) [details]
| Usman, Nassim; Polisky, Barry; et al.
Ribozyme Pharmaceuticals, Inc., USA
| PCT Int. Appl.
WO2003070966 |
| 9. Methods for cyclophane-like compounds and macrocyclic compounds having reactive functional groups [details]
| Cook, Phillip Dan
Isis Pharmaceuticals, Inc., USA; Cook, Phillip Dan
| PCT Int. Appl.
WO9810286 |
| 10. Preparation of tertiary N-(5,6,7,8-tetrahydro-8-quinolinyl)-N-(1H-benzimidazol-2-ylmethyl)amines and analogs as chemokine receptor modulators for treatment of HIV or FIV [details]
| Bridger, Gary; Skerlj, Renato; et al.
Anormed Inc., Can.
| PCT Int. Appl.
WO2002034745 |
